drugset / Trial / NCT01663961

A Study to Evaluate the Effect of a Single Dose of Digoxin on the Actions in the Bodies of Healthy Subjects After Having Taken Several Doses of YM178

NCT01663961

Phase 1 Completed 25 enrolled Astellas Pharma Europe B.V.
NaSingle-groupOpen-labelBasic science

Summary

A study that evaluates the interaction in healthy subjects of the heart drug Digoxin on YM178, when the latter is taken on a continuous basis, in order to establish that there is no risk to patients who may take this combination of drugs.

Timeline

Start
2008-09
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Digoxin Other / unclassified Oral
Subject Mirabegron Other / unclassified Oral

Indications

No indication recorded.